Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Analgesic Effect of an Injection of Botulinum Toxin Type A in the Ganglion Impar in Patients With Chronic Proctalgia (Impartox)

This study has been completed.
Information provided by (Responsible Party):
Nantes University Hospital Identifier:
First received: March 31, 2011
Last updated: October 4, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)